dr. copeland on the use of parp inhibitors in ovarian cancer
Published 4 years ago • 42 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:05
dr. copeland on the etiology of ovarian cancer
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer
-
0:43
dr. copeland on the importance of germline testing in ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:41
dr. copeland on the role of chemotherapy in ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
1:22
dr. copeland on the prevalence of ovarian cancer in the united states
-
0:48
dr. crane on the impact of parp inhibitors in ovarian cancer
-
1:37
dr. konecny on the use of parp inhibitors in patients with ovarian cancer
-
1:11
dr. cosgrove on the utilization of parp inhibition in ovarian cancer
-
0:53
dr. mirza on the impact of parp inhibitors in ovarian cancer
-
0:45
dr. coffman on safety concerns with parp inhibitors in ovarian cancer
-
1:18
dr. o'malley on the tolerability of parp inhibitors in ovarian cancer
-
34:13
expert views on the evolving role of parp inhibitors in the treatment of ovarian cancer
-
1:10:07
optimizing the use of parp inhibitors in ovarian cancer
-
1:11
dr. berek discusses the impact of parp inhibitors on ovarian cancer